Login / Signup

Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 "SLC34A2" in Papillary Thyroid Carcinoma: An Immunohistochemical Study.

Sarah Adel HakimRasha Mohamed Abd El AttiReham Mohamed FaheimHoda Hassan Abou Gabal
Published in: Analytical cellular pathology (Amsterdam) (2021)
High SLC34A2 IHC expression correlated with adverse clinicopathological prognostic parameters. Furthermore, SLC34A2 was identified as an independent factor for DFS that could serve to improve risk stratification of PTC patients for better management.
Keyphrases